Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ensysce Biosciences, Inc. - Common Stock
(NQ:
ENSC
)
3.310
-0.360 (-9.81%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ensysce Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Ensysce Biosciences, Inc. Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds
Today 16:15 EDT
Via
ACCESS Newswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Today 13:05 EDT
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Today 8:06 EDT
Via
Benzinga
Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Today 5:30 EDT
Via
Benzinga
Ensysce Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results
March 10, 2025
Via
ACCESS Newswire
Ensysce Biosciences Reports Continued Positive Progress in Groundbreaking Trial on PF614-MPAR, Comments on Current Landscape for Pain Treatment
February 05, 2025
Via
ACCESS Newswire
Top movers in Wednesday's after hours session
April 23, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
Ensysce Biosciences Stock Doubles In One Trading Session - Here's Why
April 23, 2025
Ensysce Biosciences rises after patent notice for PF9001, a methadone prodrug aimed at safer opioid use with overdose protection technology.
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 23, 2025
Via
Benzinga
Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds
April 23, 2025
Via
ACCESS Newswire
Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR
January 22, 2025
Via
ACCESS Newswire
Ensysce Biosciences Issues Annual Shareholder Letter
January 08, 2025
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 23, 2025
Via
Benzinga
Crude Oil Falls Over 3%; Philip Morris Earnings Top Views
April 23, 2025
Via
Benzinga
Exposures
Fossil Fuels
Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results
April 23, 2025
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 23, 2025
Via
Benzinga
Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product
December 10, 2024
Via
ACCESSWIRE
Ensysce Biosciences Announces Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPAR
December 04, 2024
Via
ACCESSWIRE
Ensysce Biosciences Receives U.S. Patent for Groundbreaking Treatment of Opioid Use Disorder
April 23, 2025
Via
ACCESS Newswire
Ensysce Biosciences Stock Rises On Positive Data From Opioid Overdose Protection Study: Retail’s Thrilled
April 15, 2025
The company stated that a 100 mg dosage of PF614-MPAR delivers oxycodone to treat severe pain and provides overdose protection when a greater-than-prescribed dose is consumed.
Via
Stocktwits
Topics
Government
Exposures
Political
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 15, 2025
Via
Benzinga
Ensysce Biosciences Announces Positive Data from Opioid Overdose Protection Study
April 15, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 10, 2025
Via
Benzinga
Ensysce Biosciences, Inc. Announces $1.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
March 31, 2025
Via
ACCESS Newswire
Ensysce Biosciences Announces PAINWeek 2025 Symposium and Recent Expert Panel Discussion on The State of the Nation in Pain
March 18, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Thursday's After-Market Session
March 13, 2025
Via
Benzinga
Ensysce Biosciences to Participate in the 37th Annual ROTH Conference
March 05, 2025
Via
ACCESS Newswire
Ensysce Biosciences Regains Full Compliance with Nasdaq
December 23, 2024
Via
ACCESSWIRE
Why Marvell Technology Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
December 04, 2024
Via
Benzinga
Ensysce Biosciences Announces 1-for-15 Reverse Stock Split
December 03, 2024
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.